Johnson & Johnson
Change company Symbol lookup
Select an option...
JNJ Johnson & Johnson
PTI Proteostasis Therapeutics Inc
CALB California BanCorp
$NOPM2 Refinitiv Norway Metal & Mining Inde
EBAY eBay Inc
PTON Peloton Interactive Inc
GO Grocery Outlet Holding Corp
NUE Nucor Corp
SJM J M Smucker Co
KR Kroger Co
Go

Health Care : Pharmaceuticals | Large Cap Blend
Company profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Postmarket

Last Trade
Delayed
$144.00
0.13 (0.09%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$143.87
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
144.77
Day's Low
143.61
Volume
(Heavy Day)
Volume:
11,035,965

10-day average volume:
7,026,433
11,035,965

Vaccines Market to Advance Impressively, Exhibit a CAGR of 10.7% and Reach USD 104.87 Billion by 2027

7:48 am ET October 21, 2020 (Globe Newswire) Print

The global vaccines market size is expected to reach USD 104.87 billion by 2027, exhibiting a CAGR of 10.7% during the forecast period. The ongoing clinical trials for COVID-19 vaccine will have a tremendous impact on the global market.

KEY INDUSTRY DEVELOPMENTS:

-- September 2019: Kenya joined Ghana and Malawi by launching the world's first malaria vaccines. The malaria vaccines pilot program is fully underway as malaria affects millions of people in Africa.

-- April 2019: World Health Organization (WHO) welcomed the world's first malaria vaccine by the government of Malawi's landmark pilot program which was launched in Africa.

-- May 2019: Sanofi Pasteur received USFDA green signal for its dengue fever DENGVAXIA for launch in the U.S.

Inquire Before Buying: https://www.fortunebusinessinsights.com/enquiry/queries/vaccines-market-101769

This market report sheds light on:

-- Thorough analysis of all the parts

-- Enlightening data and figures

-- In-depth information about industry players

-- Progressing developments in the industry

-- COVID-19 impact on the market

The whole world is battling with the newly originated virus. The authorities of several countries have initiated lockdown to prevent the spread of coronavirus. Such plans have caused disturbances in the production and supply chain. But, with time and resolution, we will be able to combat this stern time and get back to normality. Our well-revised reports will help companies to receive in-depth information about the present scenario of every market so that you can adopt the necessary strategies accordingly.

To get to know more about the short-term and long-term impacts of COVID-19 on this market, please visit: https://www.fortunebusinessinsights.com/industry-reports/vaccines-market-101769

Strong Demand for Pocket-friendly Immunization to Boost Growth

The increasing supply of various products to cater to the need of patients will have a positive influence on the market. The surge in unmet needs along with the global aim to eradicate endemic diseases will encourage the development of vaccines. The united focus of pharmaceutical companies, government foundations, international organizations, and hospitals towards cost-effective vaccines and immunization therapies for people around the world.

The active government scrutiny for vaccines at a minimum cost or no cost for every individual will further incite market development in the forthcoming years. For instance, the pneumococcal conjugate vaccine was rolled out by the Universal Immunization Programme (UPI) to 21 lakh children in Himachal Pradesh and parts of Bihar in India. The increasing R&D investment by companies for novel products will further escalate market demand, which, in turn, will bode well for the market.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/vaccines-market-101769

Low Adoption of Vaccines Amid COVID-19

The postponement of immunization campaigns and reduction in the vaccination rate during pandemic has produced major concerns. According to the GAVI, the ceasing of immunizations will result in a lack of vaccination for 13.5 million people from the least developed countries. The decline in pneumococcal vaccine supply will further limit market expansion during coronavirus pandemic.

The lower adoption of vaccines in lower- and middle-income nations will subsequently dampen the growth of the market. However, the potential pipeline drugs for coronavirus is expected to contribute enormously to the growth of the market. For Pfizer, Johnson and Johnson, and other players are running clinical trials for potential candidates, which will soon be released after regulatory approvals.

Quick Buy - Vaccines Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/101769

Presence of Eminent Manufacturers to Influence Growth in North America

The market in North America generated a revenue of USD 24.88 billion in 2019 and is expected to remain dominant during the forecast period. The growth in the region is attributed to the presence of key manufacturers in the region. The increasing awareness regarding vaccination along with secure government policies for healthcare will further support expansion in the region.

Asia Pacific is expected to witness a rapid growth rate during the forecast period due to the increasing population in India and China. The growing demand for vaccines will have a positive effect on the market. Europe is expected to account for a significant share owing to the increasing demand for immunization. The prevalence of chronic diseases will spur opportunities for the market in the region.

The Report Lists the Main Companies in the Vaccines Market:

-- GlaxoSmithKline plc. (Brentford, United Kingdom)

-- Sanofi (Paris, France)

-- Pfizer Inc. (New York, United States)

-- Merck & Co., Inc. (New Jersey, United States)

-- Novartis AG (Basel, Switzerland)

-- Emergent BioSolutions, Inc. (Maryland, United States)

-- CSL Limited (Melbourne, Australia)

-- Inovio Pharmaceuticals, Inc. (Pennsylvania, United States)

-- Bavarian Nordic (Denmark)

-- Mitsubishi Tanabe Pharma Corporation (Osaka, Japan)

-- Other Prominent Players

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/vaccines-market-101769

Global Vaccines Market Segmentations:

By Type

? Recombinant/Conjugate/Subunit

? Inactivated

? Live Attenuated

? Toxoid

By Route of Administration

? Parenteral

? Oral

By Age Group

? Pediatric

? Adults

By Distribution Channel

? Hospital & Retail Pharmacies

? Government Suppliers

? Others

By Geography

? North America (U.S. and Canada)

? Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

? Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)

? Latin America (Brazil, Mexico, and Rest of Latin America)

? Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)

Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/vaccines-market-101769

SECONDARY DATA SOURCES THAT WE REFER TO:

-- Annual reports, investor presentation, SEC filings, and press releases of companies operating in the market

-- Studies published by relevant associations MedTech Europe; American College of Radiology; Cancer Council Australia; Japan Hospital Association, etc.), government sources (Centers for Disease Control & Prevention, Ministry of Health, Labour & Welfare, Japan; National Health Service, England, etc.), international organizations (World Health Organization, The Organization for Economic Co-operation and Development, Eurostat, etc.), and articles published by Research Gate, NCBI, etc.

-- Website, reports, and press releases of end user facilities - Hospitals, Ambulatory Surgery Centres, Clinics

-- Industry journals and paid databases

SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:

-- Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies

-- Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.

-- Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility

-- Number of procedures and average price of procedures

-- Replacement rate and pricing of capital equipment

-- Market dynamics in relation to the market under focus - Drivers, restraints, trends, and opportunities

-- Market & technological trends, new product developments, product pipeline.

Have a Look at Related Reports:

Veterinary/Animal Vaccines Market Share & Industry Analysis, By Product (Inactivated, Live Attenuated, Recombinant, Others), By Animal (Companion, Livestock), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, Others) and Regional Forecast, 2019-2026

Aesthetic/Cosmetic Lasers Market Share & Industry Analysis, By Application (Hair Removal, Pigmentation & Tattoo Removal, Body Shaping & Tightening, Skin rejuvenation, Acne Reduction, and Others), By End User (Hospitals and Specialty Clinics) and Regional Forecast, 2019-2026

Hearing Aids Market Share & Industry Analysis, By Product (Hearing Devices, Hearing Implants), By Patient Type (Adult, Pediatric), By Distribution Channel (OTC (Over the Counter), Medical Channel/ Hospital Pharmacies, Private Practice/ Retail Pharmacies) and Regional Forecast, 2019-2026

Microfluidic Devices Market Share & Industry Analysis, By Device Type (Chips, Sensors, and Others), By Material (Glass, Silicon, Polymer and Others), By Applications (Pharmaceutical & Life Science Research, Diagnosis & Treatment, and Others), By End-user (Diagnostic Centers, Research Institutes, Pharmaceutical and Biotechnology Companies, Healthcare Facilities and Others) and Regional Forecast, 2019-2026

Blood Glucose Monitoring Systems Market Share & Industry Analysis, By Device (Continuous Blood Glucose Monitoring Systems, Self-monitoring of Blood Glucose Systems), By Type (Invasive, Non-invasive), By Modality (Wearable, Non-wearable), By Distribution Channel (Institutional Sales, Retail Sales), and Regional Forecast 2019-2026

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights(TM) Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Fortune Business Insights(TM)

LinkedIn | Twitter | Blogs

Press Release: https://www.fortunebusinessinsights.com/press-release/vaccines-market-9430

https://ml.globenewswire.com/media/05408ba1-26b1-4fdd-8f48-1af4df373348/small/fbi-logo-tm-png.png

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.